Revenue of $2.3 million up 132% over prior year
Gross margin of 73% up 500 basis points over prior year
Q1 cash used in operations decreased 14% to $2.1 million
Conference call begins at 4:30 p.m. Eastern time today
BOSTON, Mass. (May 5, 2021) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months ended March 31, 2021. Read more.